Analysis 1.5. Comparison 1 Subcutaneous sumatriptan 4 mg versus placebo, Outcome 5 Any adverse event within 24 h.
Review: Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults
Comparison: 1 Subcutaneous sumatriptan 4 mg versus placebo
Outcome: 5 Any adverse event within 24 h
![]() |